Fresh Equities
Raises
Research
About
Looking for more information?

Contact our responsive and friendly client services team any time.

BIO-GENE TECHNOLOGY LTD

INVESTOR PRESENTATION - BIO-GENE TECHNOLOGY LTD

ASX:BGT

BIO-GENE TECHNOLOGY LTD

Materials

Bio-Gene Technology Ltd (BGT) is an Australian public biotechnology company that is developing a patent protected product platform as a new class of insecticides. Bio-Gene owns patents covering the use of these -triketone insecticides for insect control. Bio-Gene's is developing two products targeted at different sectors of the insecticide market. The natural product Qcide - is an oil extracted from the leaves of a rare cultivar of an Australian eucalypt, the Gympie Messmate (Eucalyptus cloeziana). This product is focused on organic insect control. FLAVOCIDE - is a chemically synthesised product developed as a nature identical molecule to molecules also found in Eucalyptus cloeziana extracts.

Read more

Market Cap

30.22m

Price at Close

$0.2

4w avg. Volume

673.82k

4w avg. Turnover

$119.51k

Announcements
announcementt+2 movementdate
  • Appendix 2A

    Issued Capital

  • -

    23 Sep 2020

-

23 Sep 2020
  • Update - Non-executive Director Kevin Rumble

    Company Administration

  • -

    23 Sep 2020

-

23 Sep 2020
  • Change of Director's Interest Notice

    Shareholder Details

  • +5.71%

    16 Sep 2020

+5.71%

16 Sep 2020
  • Change of Director's Interest Notice

    Shareholder Details

  • +5.71%

    16 Sep 2020

+5.71%

16 Sep 2020
  • Change of Director's Interest Notice

    Shareholder Details

  • +5.71%

    16 Sep 2020

+5.71%

16 Sep 2020
  • Successful Stage 2 Completion of Program with BASF and GRDC

    Progress Report · Market sensitive

  • 0.00%

    08 Sep 2020

0.00%

08 Sep 2020
  • Response to ASX Price and Volume Query

    ASX Query · Market sensitive

  • 0.00%

    08 Sep 2020

0.00%

08 Sep 2020
  • Appendix 4G and 2020 Corporate Governance Statement

    Periodic Reports

  • -3.57%

    26 Aug 2020

-3.57%

26 Aug 2020
  • Appendix 4E and 2020 Annual Report

    Periodic Reports · Market sensitive

  • -3.57%

    26 Aug 2020

-3.57%

26 Aug 2020
  • Change of Director's Interest Notice - P May

    Shareholder Details

  • +3.70%

    30 Jul 2020

+3.70%

30 Jul 2020
Market Data

Current Price

$0.2

52WK HIGH

$0.32

52WK LOW

$0.1

1YR RETURN

+21.21%

1YR RETURN VS. SECTOR

+34.19%

90 DAY RETURN

+42.86%

ASX RANK

1,239

/2,018

SECTOR RANK

5

/8

SHARES OUTSTANDING

151.12m
ASX:BGT

BIO-GENE TECHNOLOGY LTD

Materials

Bio-Gene Technology Ltd (BGT) is an Australian public biotechnology company that is developing a patent protected product platform as a new class of insecticides. Bio-Gene owns patents covering the use of these -triketone insecticides for insect control. Bio-Gene's is developing two products targeted at different sectors of the insecticide market. The natural product Qcide - is an oil extracted from the leaves of a rare cultivar of an Australian eucalypt, the Gympie Messmate (Eucalyptus cloeziana). This product is focused on organic insect control. FLAVOCIDE - is a chemically synthesised product developed as a nature identical molecule to molecules also found in Eucalyptus cloeziana extracts.

Read more

Market Cap

30.22m

Price at Close

$0.2

4w avg. Volume

673.82k

4w avg. Turnover

$119.51k

ASX:BGT is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.